Cargando…

Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

BACKGROUND: We developed a personalized Monocyte-Derived Dendritic-cell Therapy (MDDCT) for HIV-infected individuals on suppressive antiretroviral treatment and evaluated HIV-specific T-cell responses. METHODS: PBMCs were obtained from 10 HIV(+) individuals enrolled in trial NCT02961829. Monocytes w...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Almeida Baptista, Marcella Vassão, da Silva, Laís Teodoro, Samer, Sadia, Oshiro, Telma Miyuki, Shytaj, Iart Luca, Giron, Leila B., Pena, Nathalia Mantovani, Cruz, Nicolly, Gosuen, Gisele Cristina, Ferreira, Paulo Roberto Abrão, Cunha-Neto, Edécio, Galinskas, Juliana, Dias, Danilo, Sucupira, Maria Cecilia Araripe, de Almeida-Neto, Cesar, Salomão, Reinaldo, da Silva Duarte, Alberto José, Janini, Luís Mário, Hunter, James R., Savarino, Andrea, Juliano, Maria Aparecida, Diaz, Ricardo Sobhie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753935/ https://www.ncbi.nlm.nih.gov/pubmed/35022035 http://dx.doi.org/10.1186/s12981-021-00426-z

Ejemplares similares

High prevalence and incidence of HIV-1 in a counseling and testing center in the city of Itajaí, Brazil
por: Grinberg, Gorki, et al.
Publicado: (2015)

A cure for AIDS: a matter of timing?
por: Shytaj, Iart Luca, et al.
Publicado: (2013)

Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS
por: Savarino, Andrea, et al.
Publicado: (2015)

Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy
por: Giron, Leila Bertoni, et al.
Publicado: (2019)

Nicotinamide activates latent HIV-1 ex vivo in ART suppressed individuals, revealing higher potency than the association of two methyltransferase inhibitors, chaetocin and BIX01294
por: Samer, Sadia, et al.
Publicado: (2020)

A scalable workflow to test “shock and kill” therapeutic approaches against the HIV-1 latent reservoir in blood cells ex vivo
por: Procopio, Francesco Andrea, et al.
Publicado: (2023)

Correction: Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment
por: Scarpellini, Bruno, et al.
Publicado: (2017)

Analysis of HIV-1 Protease Gene Reveals Frequent Multiple Infections Followed by Recombination among Drug Treated Individuals Living in São Paulo and Santos, Brazil
por: Nunes, Edsel Renata De Morais, et al.
Publicado: (2014)

Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?
por: da Silva, Laís Teodoro, et al.
Publicado: (2018)

Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment
por: Scarpelini, Bruno, et al.
Publicado: (2016)

Uniquely altered transcripts are associated with immune preservation in HIV infection
por: Zanoni, Michelle, et al.
Publicado: (2017)

Epigenetic Modulations in Activated Cells Early after HIV-1 Infection and Their Possible Functional Consequences
por: Maricato, Juliana T., et al.
Publicado: (2015)

HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country
por: Nutini, Mariana Fernanda Rodrigues, et al.
Publicado: (2020)

Faster HIV-1 Disease Progression among Brazilian Individuals Recently Infected with CXCR4-Utilizing Strains
por: Sucupira, Maria Cecilia Araripe, et al.
Publicado: (2012)

Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
por: Blum, Vinicius Fontanesi, et al.
Publicado: (2021)

Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.
por: Blum, Vinicius Fontanesi, et al.
Publicado: (2021)

Glycolysis downregulation is a hallmark of HIV‐1 latency and sensitizes infected cells to oxidative stress
por: Shytaj, Iart Luca, et al.
Publicado: (2021)

Analysis of protease treatment-associated mutations in a group of HIV-1 subtype F infected individuals with two sequences obtained in different time points
por: Oliveros, Márcia Perez Resende, et al.
Publicado: (2010)

Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil
por: Diaz, Ricardo Sobhie, et al.
Publicado: (2023)

Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine
por: Oshiro, Telma Miyuki, et al.
Publicado: (2022)

Understanding COVID-19 progression with longitudinal peripheral blood mononuclear cell proteomics: Changes in the cellular proteome over time
por: Figueirêdo Leite, Giuseppe Gianini, et al.
Publicado: (2023)

Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment
por: Taibe, Noha Samir, et al.
Publicado: (2022)

Data on inflammasome gene polymorphisms of patients with sporadic malignant melanoma in a Brazilian cohort
por: da Silva, Wanessa Cardoso, et al.
Publicado: (2016)

Prevalence of anti-SARS-CoV-2 antibodies in outpatients of a large public university hospital in Sao Paulo, Brazil
por: Oliveira, Luanda Mara da Silva, et al.
Publicado: (2020)

A Highly Intensified ART Regimen Induces Long-Term Viral Suppression and Restriction of the Viral Reservoir in a Simian AIDS Model
por: Shytaj, Iart Luca, et al.
Publicado: (2012)

What Happens to the Immune System after Vaccination or Recovery from COVID-19?
por: Tiyo, Bruna T., et al.
Publicado: (2021)

Fitness Cost of Antiretroviral Drug Resistance Mutations on the pol Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure
por: Hunter, James R., et al.
Publicado: (2021)

Antiretroviral Drug-Resistance Mutations on the Gag Gene: Mutation Dynamics during Analytic Treatment Interruption among Individuals Experiencing Virologic Failure
por: Hunter, James R., et al.
Publicado: (2022)

Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS
por: Shytaj, Iart Luca, et al.
Publicado: (2013)

Exosomes from patients with septic shock convey miRNAs related to inflammation and cell cycle regulation: new signaling pathways in sepsis?
por: Real, Juliana Monte, et al.
Publicado: (2018)

Amphibian Beta Diversity in the Brazilian Atlantic Forest: Contrasting the Roles of Historical Events and Contemporary Conditions at Different Spatial Scales
por: da Silva, Fernando Rodrigues, et al.
Publicado: (2014)

The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use
por: Diaz, Ricardo Sobhie, et al.
Publicado: (2015)

Mitochondria as a Cellular Hub in Infection and Inflammation
por: Andrieux, Pauline, et al.
Publicado: (2021)

Chagas Disease Cardiomyopathy: Immunopathology and Genetics
por: Cunha-Neto, Edecio, et al.
Publicado: (2014)

SARS-CoV-2 recombinant proteins stimulate distinct cellular and humoral immune response profiles in samples from COVID-19 convalescent patients
por: da Silva, Laís Teodoro, et al.
Publicado: (2021)

Thalidomide is Associated With Increased T Cell Activation and Inflammation in Antiretroviral-naive HIV-infected Individuals in a Randomised Clinical Trial of Efficacy and Safety
por: Vergara, Tânia R.C., et al.
Publicado: (2017)

Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy
por: Chevillard, Christophe, et al.
Publicado: (2018)

Editorial: Mitochondria at the Crossroads of Immunity and Inflammatory Tissue Damage
por: Nunes, João Paulo Silva, et al.
Publicado: (2021)

Progression of Type 1 Diabetes: Circulating MicroRNA Expression Profiles Changes from Preclinical to Overt Disease
por: Santos, Aritania Sousa, et al.
Publicado: (2022)

Alterations of redox and iron metabolism accompany the development of HIV latency
por: Shytaj, Iart Luca, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n7if976fvjba649h9rm20ddsev